The objective of this study was to assess the efficacy and safety of adefovir dipivoxil / adv ( hepsera ) therapy under compassionate use in patients with chronic hepatitis b ( chb ) and lamivudine resistance 本文的目的就是研究阿德福伟在对拉米夫定耐药的慢性乙肝患者当中使用的安全性和有效性。
2.
Some patients receiving adefovir dipivoxil ( hepsera ) at the approved dose of 10 mg daily for the treatment of chronic hepatitis b virus ( hbv ) infection have a suboptimal virological response characterized by a slow and moderate decrease in hbv replication 有些接受阿德福韦核准每天10毫克药量治疗慢性乙肝感染的患者常出现缓慢，中度减低病毒复制的不佳抗病毒效应。
